Rofecoxib is used to treat osteoarthritis, not osteoporosis. Estrogen is the initial drug of choice for both prevention and treatment of osteoporosis. It can be given by an oral or transdermal route and in combination with progesterone when needed. Alendronate and risedronate are approved bisphosphonates for prevention and treatment of osteoporosis. Raloxifene is the only approved selective estrogen receptor modulator for prevention and treatment of osteoporosis. Raloxifene is an option for patients who cannot or will not take estrogen. Calcitonin is approved for both prevention and treatment of osteoporosis.
Click here to return to the questions
Seminars in Medical Practice
Hospital Physician Board Review Manuals
Copyright © 2009, Turner White Communications
Updated 1/04/08 kkj